Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Head and Neck Cancer

  Free Subscription


29.09.2025

1 Ann Surg
1 Br J Oral Maxillofac Surg
1 Cancer Res
3 Dis Esophagus
1 Head Neck
1 Histopathology
2 Int J Cancer
2 J Clin Endocrinol Metab
4 Oral Oncol
1 PLoS Comput Biol
2 PLoS One
1 Radiol Imaging Cancer


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg

  1. WANG J, Wu Z, Verhoeven RHA, Goense L, et al
    A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy: A Study Based on the Netherlands Cancer Registry.
    Ann Surg. 2025 Sep 23. doi: 10.1097/SLA.0000000000006869.
    PubMed         Abstract available


    Br J Oral Maxillofac Surg

  2. SCHEMBRI T, Oikonomou C, Holmes S
    Adapting the University of Washington Quality of Life Questionnaire for Oral Cancer to trauma patients.
    Br J Oral Maxillofac Surg. 2025 Aug 8:S0266-4356(25)00200.
    PubMed         Abstract available


    Cancer Res

  3. ZHANG D, Hu J, Zhu G, Liu C, et al
    CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-24-3866.
    PubMed         Abstract available


    Dis Esophagus

  4. STRAATMAN J, Abu Hejley A, Klevebro F, Fuchs H, et al
    Analysis of in-hospital mortality following transthoracic esophagectomy for cancer.
    Dis Esophagus. 2025;38:doaf076.
    PubMed         Abstract available

  5. KOOIJ CD, Goense L, Kingma BF, den Boer RB, et al
    Early versus late oral feeding regimens following esophagectomy: a propensity score-matched observational cohort.
    Dis Esophagus. 2025;38:doaf068.
    PubMed         Abstract available

  6. DE MUL N, Vernooij LM, van Haastregt NCJ, de Groot EM, et al
    Judicious use of critical care resources by predicting the need for routine ICU admission following esophagectomy.
    Dis Esophagus. 2025;38:doaf075.
    PubMed         Abstract available


    Head Neck

  7. WANG J, Ludwig ML, Kulkarni A, Birkeland AC, et al
    CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2025 Sep 23. doi: 10.1002/hed.70048.
    PubMed         Abstract available


    Histopathology

  8. PATIL A, Jiezhen TL, Kosiorek H, Brown IS, et al
    An international inter-rater agreement study in the challenging diagnosis of squamous dysplasia of the oesophagus.
    Histopathology. 2025;87:573-583.
    PubMed         Abstract available


    Int J Cancer

  9. VERHOEVEN RHA, Kuijper SC, Slingerland M, Wijnhoven B, et al
    Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival.
    Int J Cancer. 2025 Sep 23. doi: 10.1002/ijc.70168.
    PubMed         Abstract available

  10. OSWAL K, Barman S, Kerr AR, Zaman M, et al
    Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India.
    Int J Cancer. 2025 Sep 19. doi: 10.1002/ijc.70160.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  11. XU X, Zhang C, Wang G, Dong B, et al
    Correlation of TgAb With Clinicopathological Features and Unfavorable Efficacy of 131I Ablation in PTC.
    J Clin Endocrinol Metab. 2025;110:e3245-e3251.
    PubMed         Abstract available

  12. CIRELLO V, Colombo C, Tosi D, Manzo A, et al
    TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer.
    J Clin Endocrinol Metab. 2025 Feb 1:dgaf056. doi: 10.1210.
    PubMed         Abstract available


    Oral Oncol

  13. SAMUEL M
    Disparities in oral cancer screening in India: reflections on NFHS 5 evidence and pathways forward.
    Oral Oncol. 2025;169:107693.
    PubMed         Abstract available

  14. MISRA SR, Das R
    Financial instability, insurance, and transportation barriers in oral cancer care: contrasting perspectives between the United States and India.
    Oral Oncol. 2025;169:107692.
    PubMed        

  15. CHENG H, Jiang M, Kim S, Moshiri A, et al
    Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma.
    Oral Oncol. 2025;170:107687.
    PubMed         Abstract available

  16. AL MAQRASHI ZAA, Kartolo A, Meyers BM
    Resectable locally advanced head and neck squamous cell carcinoma: cut first or immune checkpoint inhibitors first?
    Oral Oncol. 2025;170:107704.
    PubMed        


    PLoS Comput Biol

  17. COLEGROVE HL, Monnat RJ Jr, Feder AF
    Epithelial competition determines gene therapy potential to suppress Fanconi Anemia oral cancer risk.
    PLoS Comput Biol. 2025;21:e1012915.
    PubMed         Abstract available


    PLoS One

  18. CLATOT F, Even C, Daste A, Borel C, et al
    Defining a need for rapid response and practical guidance for recurrent and metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) management in France: A Delphi consensus.
    PLoS One. 2025;20:e0332413.
    PubMed         Abstract available

  19. LIN R, Qin R, Zhang Y, Guan Y, et al
    Combined application of BNLF2b antibody with VCA-IgA, Rta-IgG, and Zta-IgA in nasopharyngeal carcinoma screening in the Guangxi region.
    PLoS One. 2025;20:e0332606.
    PubMed         Abstract available


    Radiol Imaging Cancer

  20. JAIN S
    Metabolic Response at (18)F-FDG PET/CT as a Prognostic Marker after Induction Chemotherapy or Chemoradiotherapy in Localized Esophageal Squamous Cell Carcinoma.
    Radiol Imaging Cancer. 2025;7:e259024.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.